Nėra interneto ryšio – rodoma išsaugota puslapio versija.

Opko Health Inc

USUSD
← Į akcijų filtrą
US:OPKLSE:0KCS

Opko Health Inc (US:OPK) — Biotechnology: Pharmaceutical Preparations. Biržų, kuriose prekiaujama bendrovės akcijomis, skaičius: 2. Šiame puslapyje — kaina ir grafikas, dividendai, didžiausi akcininkai ir akcijų skaičiaus istorija.

Apie įmonę

Svetainė
opko.com
Sektorius
Health Care · Biotechnology: Pharmaceutical Preparations
Būstinė
Miami, United States
Generalinis direktorius
Dr. Phillip Frost M.D., Ph.D.
Darbuotojai
2 275
Įkurta
1991
Apyvartoje esančios akcijos
746.33 mln. 2026-07-17 duomenimis
Laisvai apyvartinės akcijos
323.73 mln.
Rinkos kapitalizacija
1.17 mlrd. USD
Insaideriai
50.52%
Instituciniai investuotojai
27.56%
Šaka (SIC)
Pharmaceutical Preparations
ISIN
US68375N1037
LEI
529900A4S2D4OGOJLL02
Aprašymas

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency. The Diagnostics segment offers laboratory testing services, such as detection, diagnosis, evaluation, monitoring, and treatment of diseases, as well as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare under the BioReference brand; and 4Kscore test. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida.

Biržos ir tikeriai

BiržaTikerisValiutaKainaTipas
US USA StocksOPK pagrindinisUSD1.37 -1.44%paprastosios akcijos
LSE London Stock Exchange0KCS IOBUSD1.64 +0.00%paprastosios akcijos

Kaina per 3 mėnesius

kilimo diena kritimo diena dividendų ex data išmokėjimo dataUžveskite / palieskite dieną — atidarymo, uždarymo, aukščiausia ir žemiausia kainos

Dividendai

Dividendų išmokų nerasta (patikrinta 09.10.2026). Įmonė greičiausiai nemoka dividendų.

Šios savaitės naujienos

Per pastarąją savaitę jokių naujienų. Naujausios naujienos: 08.09.2026.

reklama

Didžiausi akcininkai

TurėtojasDalisAkcijosAtaskaitos data
Rubric Capital Managemen…6.4%47.79 mln.2026-06-30
Blackrock Inc.4.95%36.98 mln.2026-06-30
Vanguard Capital Managem…2.01%14.97 mln.2026-06-30
Vanguard Portfolio Manag…2%14.93 mln.2026-06-30
Geode Capital Management…1.55%11.58 mln.2026-06-30
iShares Trust-iShares Ru…1.38%10.32 mln.2026-08-31
State Street Corporation1.38%10.31 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…1.31%9.75 mln.2026-06-30
Goldman Sachs Group Inc0.94%7.04 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…0.93%6.92 mln.2026-06-30
UBS Group AG0.67%5.01 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…0.66%4.91 mln.2026-06-30
Whitefort Capital Manage…0.6%4.51 mln.2026-06-30
Fidelity Salem Street Tr…0.58%4.35 mln.2026-07-31
iShares Trust-iShares Ru…0.51%3.79 mln.2026-08-31
Northern Trust Corporati…0.5%3.76 mln.2026-06-30
iShares Trust-iShares Bi…0.38%2.81 mln.2026-08-31
VANGUARD INDEX FUNDS-Van…0.29%2.2 mln.2026-06-30
VANGUARD SCOTTSDALE FUND…0.28%2.11 mln.2026-05-31
SCHWAB STRATEGIC TRUST-S…0.27%2.04 mln.2026-05-31
PAGANELLI JOHN A (Direct…≈0.05%403 5152026-03-20
FROST PHILLIP MD ET AL (…——2025-11-21